HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lewis, V. Articles by Collins, S. J. Search for Related Content PubMed PubMed Citation Articles by Lewis, V. Articles by Collins, S. J. Related Collections Prion

Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles

From the Australian National Creutzfeldt–Jakob Disease Registry, Department of Pathology (Drs. Masters and Collins, V. Lewis, G.M. Klug, and A. Boyd), and Department of Biochemistry and Molecular Biology (Dr. Hill), University of Melbourne, and Mental Health Research Institute of Victoria (Drs. Hill, Masters, and Collins, V. Lewis, G.M. Klug, and A. Boyd), Parkville, Victoria, Australia.

Address correspondence and reprint requests to Dr Collins, Australian National CJD Registry, University of Melbourne, Melbourne, Victoria, Australia, 3010; e-mail: stevenjc{at}unimelb.edu.au

Objective: To define the protease-resistant prion protein (PrP^res) types and associated clinical profiles in Australian patients with sporadic Creutzfeldt–Jakob disease (CJD) to allow comparison with those reported from other continents and concomitantly reaffirm absence of variant CJD (vCJD).

Methods: Reassessment of available clinical and neuropathologic data on patients referred to the Australian National Creutzfeldt–Jakob Disease Registry (ANCJDR) who died between January 1, 1992, and June 30, 2003, was conducted. Molecular classification of PrP^res was determined by immunoblot analysis of available frozen brain tissue. Brain homogenate pH and codon 129 genotype on the prion protein gene (PRNP) were established.

Results: PrP^res patterns in 35 of 37 patients with sporadic CJD conformed to one of three common reported types. Of a range of clinical features assessed, illness duration was the only clinical feature significantly associated with PrP^res type. Two patients displayed coexistence of more than one PrP type, with one displaying a novel pattern of three PrP^res types in a single brain region. The absence of vCJD was reconfirmed, supported by the lack of the typical PrP^res glycoform pattern.

Conclusions: Given Australia’s geographic isolation and environmental uniqueness, the general congruity of these results with those reported from other continents suggests that endogenous factors predominantly determine sporadic Creutzfeldt–Jakob disease (CJD) phenotypic subtypes or "strains." These results support a clinicopathologic classification system whereby both PrP^res type and codon 129 genotype are utilized to most accurately depict phenotypic subtypes or strains of sporadic CJD.

Funded in part by a National Health and Medical Research Council (NHMRC) program grant (208978). The Australian National Creutzfeldt–Jakob disease Registry is funded by the Commonwealth Department of Health and Aging. Dr. Hill receives an NHMRC RD Wright Fellowship.

Received December 30, 2004. Accepted in final form March 25, 2005.

This article has been cited by other articles:

				I. Cali, R. Castellani, A. Alshekhlee, Y. Cohen, J. Blevins, J. Yuan, J. P. M. Langeveld, P. Parchi, J. G. Safar, W.-Q. Zou, et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics Brain, October 1, 2009; 132(10): 2643 - 2658. [Abstract] [Full Text] [PDF]

				I. Cali, R. Castellani, J. Yuan, A. Al-Shekhlee, M. L. Cohen, X. Xiao, F. J. Moleres, P. Parchi, W.-Q. Zou, and P. Gambetti Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain, September 1, 2006; 129(Pt 9): 2266 - 2277. [Abstract] [Full Text] [PDF]

				A. F. Hill, S. Joiner, J. A. Beck, T. A. Campbell, A. Dickinson, M. Poulter, J. D. F. Wadsworth, and J. Collinge Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations Brain, March 1, 2006; 129(3): 676 - 685. [Abstract] [Full Text] [PDF]